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posed to LPI were shown to exhibit a rapid, sustained, and concentration-dependent increased infarct size when applied prior to ischemia onset, but not when given at the time of reperfusion. The exacerbation of tissue injury by LPI was not seen in hearts from GPR55 −/− mice or in the presence of Y-27632, confirming that injury is mediated via the GPR55/ROCK/p38 MAPK pathway. These findings suggest that raised levels of LPI in the vicinity of a developing infarct may worsen the outcome of AMI.
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| INTRODUC TI ON
Reperfusion of an occluded artery is vital to the salvage of the myocardium affected by ischemia, however the reintroduction of blood and oxygen paradoxically causes further injury and cardiomyocyte death known as ischemia/reperfusion (I/R) injury.
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Immediate "lethal" I/R injury occurs within the first few minutes of reperfusion with the critical early events being an increase in oxidative stress, [Ca 2+ ] i overload, 13 opening of the mitochondrial permeability transition pore (MPTP 15 ) and the activation of proapoptotic pathways. 14, 26 It is well established that the release of bioactive lipids from platelets at the site of clot formation during acute myocardial infarction (AMI) contributes to the eventual extent of myocardial I/R injury, with some lipids (eg sphingosine-1-phosphate; S-1-P) exerting cardioprotective effects (reviewed in 21) and others exacerbating (eg platelet activating factor:
22,32) I/R injury. Platelets also release the lysophospholipid l-α-lysophosphatidylinositol (LPI) and are thought to be the source of the elevated plasma levels of LPI seen in patients undergoing coronary angioplasty for acute coronary syndrome (ACS 27 ). LPI acts as an endogenous ligand at the G-protein coupled receptor GPR55 36 which is expressed in various rodent 40 and human 18 tissues including the cardiovascular system, where it is expressed on vascular smooth muscle and endothelial cells 6, 7 and ventricular cardiomyocytes. 45, 52 Although the functional importance of the GPR55/LPI system in cardiovascular physiology and pathophysiology is poorly understood, we have previously shown that mice lacking GPR55 exhibit moderate systolic dysfunction with age and have a decreased contractile reserve in response to adrenoceptor stimulation, 45 suggesting a physiological role in maintaining cardiac function. In contrast, observations that GPR55 tissue expression and circulating levels of LPI are raised in conditions where there is heightened cardiovascular risk (such as obesity and metabolic syndrome 33 ); that cardiac LPI levels rise during asphyxia-induced myocardial ischemia, 24, 25 and that the GPR55 antagonist CBD reduces myocardial infarct size in rats in vivo 9,46 all point to a potential detri- ] i ) and activation of G α13.
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Similarly, LPI induces a rapid and transient increase in [Ca 2+ ] i in cardiomyocytes through an action at GPR55 receptors located on both the sarcolemma and the membranes of intracellular organelles, 52 although any involvement of RhoA/ROCK signaling in the response to LPI in cardiomyocytes remains to be investigated.
[Ca

2+
] i overload is a major factor in cardiomyocyte death following myocardial I/R 5,28 and activation of the RhoA/ROCK pathway plays an important role in the setting of I/R injury as it is activated at the time of reperfusion to suppress the RISK pathway and extend reperfusion injury.
14 Thus, our underlying hypothesis was that activation of the GPR55/RhoA/ROCK pathway by LPI in the vicinity of the ischemic myocardium, may contribute to exacerbation of I/R injury. 
| MATERIAL S AND ME THODS
| Dynamic mass redistribution (DMR) in response to LPI
The underlying principle of determining changes in cellular DMR has previously been described in detail. ; JAX background) mice were bred in-house and were routinely genotyped as previously described. 49 All animals were housed in the University of Aberdeen Medical Research Facility until experimentation at Robert Gordon University. All mice were grouped according to genotype, gender and age and housed in temperature (21 ± 2°C) and humidity (55 ± 10%) controlled rooms with a 12-hour light/ dark cycle (7 am/7 pm). Additionally, mice were housed (according to husbandry guidelines set by the UK Home Office) in groups not exceeding eight, with ad libitum access to water and food pellets and environmental enrichment. All animals (males and females) were aged between 9-12 weeks (body weights 18-32 g) at the time of use and were randomly allocated to experimental groups using random number generator software (Stat Trek, UK).
Mice were anesthetized with ketamine (120 mg/kg) and xylazine (16 mg/kg) via intraperitoneal (ip) injection and the heart rapidly excised, the aorta cannulated and the heart mounted onto a 
| Statistical analysis
For all experiments, data are expressed as mean ± SEM of n observations. For the ROCK2 phosphorylation assay, n refers to the number of experiments performed using separate cell preparations and data were expressed as a ratio of phospho-ROCK2 to ROCK2. For the Epic studies, the time courses of the responses were obtained by plotting the DMR activity (arbitrary units) measured at 1-minute intervals and peak DMR activity was determined from the time course plots and measured at the point where the response reached a maximum before either reaching a plateau or declining; n refers to the number of plates tested for each intervention. For isolated heart studies, n refers to the number of hearts or tissue samples used for the study. Power calculations performed on data from previous studies indicated that to detect a 30% difference in infarct size with 85% power, the minimum group size is 5. Therefore, all experiments employed hearts from at least five animals for each intervention.
However, since the studies were performed over several months, contemporaneous control experiments in wild type mice were included throughout to avoid any influence of seasonal variation and therefore the data were pooled, resulting in larger group sizes.
Infarct size is expressed as a percentage of total ventricular area of the tissue slice. For both cell studies and isolated heart studies, comparisons were made using either Student's unpaired t-test (twogroup comparison) or one-way ANOVA followed by a Bonferroni post-hoc test (multiple comparisons). All statistical analyses were carried out using GraphPad Prism ® 4 software (GraphPad Software, Inc. USA). In all cases a value of P < 0.05 was taken to indicate statistical significance. 
| Drugs and solutions
| RE SULTS
| Effect of LPI on cultured cardiomyocytesidentification of ROCK as a GPR55 signaling pathway
In order to explore whether LPI, acting through GPR55 and ROCK, could have an adverse effect on the outcome of AMI, it was important to initially characterize the responses to LPI in cardiomyocytes. Figure 3A and B) and was similarly GPR55 and ROCK-mediated as shown by inhibition by CBD ( Figure 3C ) and Y-27632 ( Figure 3D ), respectively.
| LPI induces ROCK and p38 MAPK phosphorylation in murine iPSC cardiomyocytes
To confirm that the changes in DMR in response to LPI were indeed ; and inverse agonism at CB 2 receptors, 37 ), the role of GPR55 in mediating the responses to LPI was further confirmed in these experiments by using the selective GPR55 antagonist CID16020046 (10 μmol L −1 ). ROCK phosphorylation by LPI was still clearly detectable after 40 minutes ( Figure 5A and B) and, as with CBD, CID16020046 completely abrogated the response providing further confirmation that this was mediated through GPR55 activation.
| LPI exacerbates I/R injury via activation of GPR55 and ROCK phosphorylation
To confirm that LPI was acting through GPR55, hearts from both WT and GPR55 −/− mice were used. Challenging WT hearts with LPI prior to the onset of global ischemia significantly increased infarct size compared to vehicle controls ( Figure 6A , B and G), whereas this was not seen in seen GPR55 −/− hearts, confirming an action of LPI at GPR55 (Figure 6E and F) . Interestingly, when LPI was applied to the hearts within the first 1-2 minutes of reperfusion, there was no increase in infarct size, indicating that the cellular mechanisms that contribute to LPI-induced injury are activated during ischemia 
| D ISCUSS I ON AND CON CLUS I ON S
The data presented from this study has shown for the first time that LPI, a platelet-derived lysophospholipid that is elevated in acute coronary syndrome, exacerbates the extent of myocardial injury and that, as in other cell types, LPI exerts its cellular responses in cardiomyocytes via activation of the GPR55 receptor and downstream activation of both ROCK and p38 MAPK. CBD and Y-27632, in both murine and human-induced pluripotent stem cell cardiomyocytes, establishing that the same signaling pathway is important in both species. In HEK293 cells, GPR55 activation leads to the recruitment of several nuclear transcription factors, all of which activate RhoA leading to phosphorylation of ROCK. 17, 19 In these present studies, we have shown for the first time that exposure of miPSC cardiomyocytes to LPI induces both ROCK and p38 MAPK activation, and that this is dependent upon an action at GPR55.
| LPI signaling in cardiomyocytes
In cardiomyocytes, one consequence of p38 MAPK activation is the induction of apoptosis, 39 however we did not see any activation
of JNK or caspase-3 (both markers of apoptosis), suggesting that the increased injury seen in the isolated hearts challenged with LPI prior to I/R was not due to induction of apoptotic cell death but to some other mechanism, such as calcium overload. would therefore be unlikely to account for the sustained response to LPI seen in the DMR studies ( Figure S1 ; unpublished observations).
| Mechanisms of LPI-induced cardiomyocyte injury
Total levels of LPI in the coronary circulation during AMI are sig- coronary circulation (to mimic exposure to platelet-derived LPI), has a detrimental influence on the outcome of an ischemia/reperfusion insult, suggesting that patients with elevated coronary LPI levels at the time of an AMI may sustain greater damage to the heart. This action of LPI is most likely to be at the level of the cardiomyocyte, since the use of a global no-flow ischemia model rules out an adverse (vasoconstrictor) effect of LPI on the coronary circulation during ischemia and, in any case, in vivo studies show that LPI causes a depressor rather than a constrictor response. 1 It is noteworthy that we did not see any difference in the extent of injury between vehicletreated WT and GPR55 −/− hearts, supporting the notion that there is no endogenous release of LPI from the heart during I/R and that the source of elevated LPI seen during acute coronary events is extracardiac. Indeed, in a separate study (manuscript in preparation), we have found that total LPI levels in WT hearts subjected to I/R are in fact significantly lower than in sham hearts. Our studies also show that administration of LPI at the time of reperfusion does not exacerbate the extent of injury, demonstrating that the LPI-induced increase in myocardial injury occurs during ischemia.
We have also confirmed that the increase in infarct size following LPI application to isolated hearts is via activation of GPR55 receptors, since infarct size in hearts from GPR55 −/− mice was not increased by LPI. Utilizing hearts lacking GPR55, as opposed to the GPR55 antagonist CBD, was a more appropriate way of demonstrating a role for the receptor since, although we know that CBD acts relatively selectively at GPR55 in cell systems, when used in whole tissue or in vivo studies it displays a more complex pharmacology. 30 Importantly, all of these studies used in vivo models and determined end points (inflammation and apoptosis) that occur over extended periods of time (hours to days) after reperfusion or implemented ROCK inhibition at the time of reperfusion. 14 In contrast, our studies were performed in blood-free perfused hearts in vitro, the hearts were administered Y-27632 prior to ischemia and relatively short (30 minutes) periods of I/R (when the main mechanisms contributing to cell death are calcium overload and oxidative stress) were used. Consistent with our findings, ROCK activation has been shown to promote cardiomyocyte survival via a PKD pathway 50 and more recent studies have
shown that the two ROCK isoforms (ROCK-1 and ROCK-2) play opposing roles in the heart, with ROCK-1 protecting against cardiac dysfunction and oxidative stress and ROCK-2 promoting these.
43
Since Y-27632 is a nonselective inhibitor that has similar affinities for both ROCK isoforms, 2 this could explain why in vehicle-treated hearts, where I/R-induced ROCK-1 activation predominates and serves a pro-survival role, Y-27632 had a slightly deleterious effect, while in LPI-stimulated hearts where ROCK-2 is activated (as shown from our cardiomyocytes studies), it prevented the ROCK-2 mediated extension of injury.
Off-target actions of Y-27632 for ROCK could also potentially account for our findings since, when screened against a panel of kinases it has been shown to inhibit protein kinase-2 (PRK2 8 ; PKC epsilon (PKCε) and protein kinase N1 (PKN). 2 The expression of PRK2 is very low in the heart, 38 making it an unlikely target, but PKN is a pro-survival kinase expressed in response to I/R injury 44 while PKCε is a known trigger of delayed preconditioning. 20, 48 Since our model F I G U R E 7 Proposed signaling pathway for LPI in cardiomyocytes that contributes to exacerbation of I/R injury. LPI is known to increase intracellular calcium in cardiomyocytes via direct entry through LTCC's and through PLC/IP 3 -mediated release from the sarcoplasmic reticulum (black arrows). Here we have shown that LPI results in both ROCK and p38 MAPK activation (blue arrows); while p38 MAPK activation has been linked to a pro-apoptotic effect during ischemia (pink), lack of evidence of activation of pro-apoptotic pathways suggests this is not the cause of LPI-induced cardiomyocyte cell injury. The proposed pathways (red arrows) are p38 MAPK-induced mitochondrial release of Ca2+ and ROS production 
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